Morgan Stanley’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $36.9M | Buy |
2,309,061
+999,011
| +76% | +$16M | ﹤0.01% | 2198 |
|
2025
Q1 | $22.4M | Buy |
1,310,050
+299,426
| +30% | +$5.12M | ﹤0.01% | 2580 |
|
2024
Q4 | $25M | Buy |
1,010,624
+192,882
| +24% | +$4.78M | ﹤0.01% | 2545 |
|
2024
Q3 | $23.3M | Buy |
817,742
+704
| +0.1% | +$20.1K | ﹤0.01% | 2651 |
|
2024
Q2 | $21.6M | Sell |
817,038
-120,923
| -13% | -$3.19M | ﹤0.01% | 2578 |
|
2024
Q1 | $30.3M | Sell |
937,961
-125,045
| -12% | -$4.04M | ﹤0.01% | 2233 |
|
2023
Q4 | $44.8M | Buy |
1,063,006
+724,123
| +214% | +$30.5M | ﹤0.01% | 2575 |
|
2023
Q3 | $13M | Sell |
338,883
-198,173
| -37% | -$7.61M | ﹤0.01% | 2873 |
|
2023
Q2 | $10.2M | Buy |
537,056
+309,965
| +136% | +$5.88M | ﹤0.01% | 3142 |
|
2023
Q1 | $3.52M | Buy |
227,091
+56,841
| +33% | +$882K | ﹤0.01% | 4066 |
|
2022
Q4 | $3.02M | Buy |
170,250
+77,819
| +84% | +$1.38M | ﹤0.01% | 4162 |
|
2022
Q3 | $516K | Sell |
92,431
-67,240
| -42% | -$375K | ﹤0.01% | 5254 |
|
2022
Q2 | $622K | Sell |
159,671
-68,351
| -30% | -$266K | ﹤0.01% | 5309 |
|
2022
Q1 | $1.26M | Sell |
228,022
-268,888
| -54% | -$1.48M | ﹤0.01% | 4844 |
|
2021
Q4 | $4.23M | Sell |
496,910
-368,336
| -43% | -$3.14M | ﹤0.01% | 3886 |
|
2021
Q3 | $7.52M | Sell |
865,246
-677,126
| -44% | -$5.88M | ﹤0.01% | 3260 |
|
2021
Q2 | $16.3M | Buy |
1,542,372
+789,721
| +105% | +$8.35M | ﹤0.01% | 2396 |
|
2021
Q1 | $12.1M | Buy |
752,651
+675,882
| +880% | +$10.8M | ﹤0.01% | 2457 |
|
2020
Q4 | $3.55M | Buy |
76,769
+71,395
| +1,329% | +$3.3M | ﹤0.01% | 3635 |
|
2020
Q3 | $190K | Sell |
5,374
-1,569
| -23% | -$55.5K | ﹤0.01% | 5145 |
|
2020
Q2 | $169K | Sell |
6,943
-13,233
| -66% | -$322K | ﹤0.01% | 5155 |
|
2020
Q1 | $314K | Buy |
20,176
+19,176
| +1,918% | +$298K | ﹤0.01% | 4638 |
|
2019
Q4 | $16K | Buy |
+1,000
| New | +$16K | ﹤0.01% | 6152 |
|